We present two patients wth amyloid goitre due to primary systemic amyloidosis which was confirmed at post-mortem. Both were clinically euthyroid but had hyperthyroxinaemia and other thyroid function tests suggestive of thyrotoxicosis.
Introduction
Whereas minor amyloid infiltration of the thyroid gland is found in 50-80% of cases of generalized amyloidosis,' the induction of a goitre by amyloid invasion is rare.2 Amyloid is an inert substance3 and infiltration of the thyroid does not usually interfere with the endocrine function of the gland.4'5 In two previous reports of possible hyperthyroidism in amyloid goitre an elevated basal metabolic rate, on which the diagnosis of hyperthyroidism rested, could instead have been attributed to the underlying chronic inflammatory disease producing the secondary amyloidosis.6 Apart from these two reports thyroid over-activity has not been noted in amyloid goitre.
We describe two cases with amyloid goitre who were clinically euthyroid but had hyperthyroxinaemia.
Case reports Case I A 50 year old manual worker presented in February 1984 with an enlarging cervical swelling, dysphagia for solids, change in voice, weight loss and feeling generally ill. Physical examination revealed a euthyroid man with pallor, a soft pitched voice and a large, diffuse, hard goitre. There was no cervical lymphadenopathy nor dysthyroid eye disease and apart from moderate hepatosplenomegaly the rest of the examination was normal.
Investigations showed a normochromic normocytic anaemia with haemoglobin 8.7 A technetium thyroid scan showed generalized 'thyroid enlargement with homogenous distribution "of radiaoactivity. The overall technetium uptake was 5.1% of the dose at 20 minutes (normal upper.level 3.5%).
Serum TSH receptor antibody activity was determined using the Rapoport bioassay which utilizes human thyroid cells in culture. The thyroid stimulating antibody level was 18 bovine TSH equivalents per ml (normal range under 2.8). Thyroglobin and microsomal antibodies were undetectable in the serum.
Carbimazole therapy was introduced in April 1984 and FT4 three months later was reduced to 7.5 pmol/l. In August 1984 carbimazole was inadvertently discontinued for 10 days and FT4, measured on the tenth day, had risen to 77.0 pmol/l. Carbimazole was promptly recommenced. Serum immunoelectrophoresis showed a paraprotein, typed as IgG Kappa. Serum immunoglobulins were assayed: IgG 28 g/l (NR 5.3-16.5); IgA 0.2 g/l (NR 0.8-4.0) and IgM 0.3 g/l (NR 0.5-2.0). A skeletal survey showed no lytic defects typical of multiple myeloma. A bone marrow aspirate contained 15% plasma cells with many abnormal forms.
A thyroid needle biopsy showed widely separated thyroid follicles some ofwhich were filled with colloid. 
